{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:52:02Z","timestamp":1793641922312,"version":"4.5.1"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Healthy skin is essential for balanced health. Currently, skin diseases are considered a\nmajor global health issue, impacting individuals of all ages. Skin conditions can vary broadly,\nranging from common issues like acne and eczema to more serious diseases such as psoriasis,\nmelanoma, and other types of skin cancer. In recent years, computational methods have appeared\nas powerful tools for explaining the lurking mechanisms of skin diseases and the advancement of\nthe discovery regarding updated therapeutics. This review spotlights the notable researches that\nhave been performed in using computational approaches such as virtual screening, molecular\nmodelling, and molecular dynamics simulations to discover potential treatments for dermatological\nconditions such as eczema, psoriasis, acne vulgaris, skin cancer, and tyrosinase-related disorders.\nMoreover, using in silico methods, researchers have explored the molecular interactions between\ncosmetic actives and skin targets, providing insights into the binding affinities, stability, and\nefficacy of these compounds. This computational exploration allows the identification of potential\noff-target effects and toxicity profiles, ensuring that only the most promising candidates proceed to\nclinical testing. In addition, the use of molecular dynamics simulations helps to understand conformational\nchanges and interaction dynamics over time, further refining the selection of effective\ncosmetic actives. Overall, the integration of computational chemistry into dermo-cosmetic research\nhas immense potential to accelerate the discovery and development of innovative treatments\nto improve skin health and address dermatological concerns.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115680266337405240926114604","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T10:40:52Z","timestamp":1729075252000},"page":"657-688","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Computational Studies in Dermo-cosmetics: In silico Discovery of Therapeutic Agents Targeting a Variety of Proteins for Skin Diseases"],"prefix":"10.2174","volume":"25","author":[{"given":"Lamiae El","family":"Bouamri","sequence":"first","affiliation":[{"name":"Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M\u2019Sik, Hassan II University of Casablanca, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bouachrine","sequence":"additional","affiliation":[{"name":"MCNS Laboratory, Faculty of Sciences, Moulay Ismail University, Meknes, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Chtita","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M\u2019Sik, Hassan II University of Casablanca, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drudis.2010.12.001","volume":"16","author":"Semlin L.","year":"2011","unstructured":"Semlin L.; Sch\u00e4fer-Korting M.; Borelli C.; Korting H.C.; In vitro models for human skin disease. Drug Discov Today  2011,16(3-4),132-139","journal-title":"Drug Discov Today"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e11991","DOI":"10.1016\/j.heliyon.2022.e11991","volume":"8","author":"Nour H.","year":"2022","unstructured":"Nour H.; Daoui O.; Abchir O.; ElKhattabi S.; Belaidi S.; Chtita S.; Combined computational approaches for developing new anti-Alzheimer drug candidates: 3D-QSAR, molecular docking and molecular dynamics studies of liquiritigenin derivatives. Heliyon  2022,8(12),e11991","journal-title":"Heliyon"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00894-022-05097-9","volume":"28","author":"Abchir O.","year":"2022","unstructured":"Abchir O.; Daoui O.; Belaidi S.; Ouassaf M.; Qais F.A.; ElKhattabi S.; Belaaouad S.; Chtita S.; Design of novel benzimidazole derivatives as potential \u03b1-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies. J Mol Model  2022,28(4),106","journal-title":"J Mol Model"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"7768","DOI":"10.1080\/07391102.2022.2124456","volume":"41","author":"Daoui O.","year":"2023","unstructured":"Daoui O.; Nour H.; Abchir O.; Elkhattabi S.; Bakhouch M.; Chtita S.; A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations. J Biomol Struct Dyn  2023,41(16),7768-7785","journal-title":"J Biomol Struct Dyn"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e01754","DOI":"10.1016\/j.sciaf.2023.e01754","volume":"21","author":"Yamari I.","year":"2023","unstructured":"Yamari I.; Abchir O.; Mali S.N.; Errougui A.; Talbi M.; Kouali M.E.; Chtita S.; The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives: An insight into molecular docking, ADMET analysis, and molecular dynamics simulation. Sci Am  2023,21,e01754","journal-title":"Sci Am"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2174\/1570180819666220510141710","volume":"20","author":"Daoui O.","year":"2023","unstructured":"Daoui O.; Elkhattabi S.; Chtita S.; Design and prediction of ADME\/Tox properties of novel magnolol derivatives as anticancer agents for NSCLC using 3D-QSAR, molecular docking, MOLCAD and MM-GBSA studies. Lett Drug Des Discov  2023,20(5),545-569","journal-title":"Lett Drug Des Discov"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e202301092","DOI":"10.1002\/slct.202301092","volume":"8","author":"Abchir O.","year":"2023","unstructured":"Abchir O.; Yamari I.; Nour H.; Daoui O.; Elkhattabi S.; Errougui A.; Chtita S.; Structure\u2010based virtual screening, ADMET analysis, and molecular dynamics simulation of Moroccan natural compounds as candidates \u03b1\u2010amylase inhibitors. ChemistrySelect  2023,8(26),e202301092","journal-title":"ChemistrySelect"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"132652","DOI":"10.1016\/j.molstruc.2022.132652","volume":"1258","author":"Belhassan A.","year":"2022","unstructured":"Belhassan A.; Chtita S.; Zaki H.; Alaqarbeh M.; Alsakhen N.; Almohtaseb F.; Lakhlifi T.; Bouachrine M.; In silico detection of potential inhibitors from vitamins and their derivatives compounds against SARS-CoV-2 main protease by using molecular docking, molecular dynamic simulation and ADMET profiling. J Mol Struct  2022,1258,132652","journal-title":"J Mol Struct"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e01986","DOI":"10.1016\/j.sciaf.2023.e01986.","volume":"23","author":"Yamari I.","year":"2024","unstructured":"Yamari I.; Abchir O.; Siddique F.; Zaki H.; Errougui A.; Talbi M.; Bouachrine M.; ElKouali M.; Chtita S.; The anticoagulant potential of Lippia Alba extract in inhibiting SARS-CoV-2 Mpro: Density functional calculation, molecular docking analysis, and molecular dynamics simulations. Sci Am  2024,23,e01986","journal-title":"Sci Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"11264","DOI":"10.1080\/07391102.2021.1957712","volume":"40","author":"Ouassaf M.","year":"2022","unstructured":"Ouassaf M.; Belaidi S.; Chtita S.; Lanez T.; Abul Qais F.; Md Amiruddin H.; Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease. J Biomol Struct Dyn  2022,40(21),11264-11273","journal-title":"J Biomol Struct Dyn"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"103316","DOI":"10.1016\/j.bioorg.2019.103316","volume":"93","author":"Zhao Z.","year":"2019","unstructured":"Zhao Z.; Liu G.; Meng Y.; Tian J.; Chen X.; Shen M.; Li Y.; Li B.; Gao C.; Wu S.; Li C.; He X.; Jiang R.; Qian M.; Zheng X.; Synthesis and anti-tyrosinase mechanism of the substituted vanillyl cinnamate analogues. Bioorg Chem  2019,93,103316","journal-title":"Bioorg Chem"},{"key":"ref=12","first-page":"1016","volume":"33","author":"Vanjare B.D.","year":"2020","unstructured":"Vanjare B.D.; Mahajan P.G.; Dige N.C.; Raza H.; Hassan M.; Han Y.; Kim S.J.; Seo S.Y.; Lee K.H.; Novel 1,2,4-triazole analogues as mushroom tyrosinase inhibitors: Synthesis, kinetic mechanism, cytotoxicity and computational studies. Mol Divers  2020,33,1016","journal-title":"Mol Divers"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"13428","DOI":"10.1021\/acs.jmedchem.0c00994","volume":"63","author":"Roulier B.","year":"2020","unstructured":"Roulier B.; P\u00e9r\u00e8s B.; Haudecoeur R.; Advances in the design of genuine human tyrosinase inhibitors for targeting melanogenesis and related pigmentations. J Med Chem  2020,63(22),13428-13443","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/DDDT.S137550","volume":"11","author":"Abbas Q.","year":"2017","unstructured":"Abbas Q.; Ashraf Z.; Hassan M.; Nadeem H.; Latif M.; Afzal S.; Seo S.Y.; Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies. Drug Des Devel Ther  2017,11,2029-2046","journal-title":"Drug Des Devel Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.3390\/molecules23123307","volume":"23","author":"Bang E.","year":"2018","unstructured":"Bang E.; Noh S.G.; Ha S.; Jung H.J.; Kim D.H.; Lee A.K.; Hyun M.K.; Kang D.; Lee S.; Park C.; Moon H.R.; Chung H.Y.; Evaluation of the novel synthetic tyrosinase inhibitor (z)-3-(3-bromo-4-hydroxybenzylidene) thiochroman-4-one (MHY1498) in vitro and in silico. Molecules  2018,23(12),3307","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"103201","DOI":"10.1016\/j.bioorg.2019.103201","volume":"92","author":"Dige N.C.","year":"2019","unstructured":"Dige N.C.; Mahajan P.G.; Raza H.; Hassan M.; Vanjare B.D.; Hong H.; Hwan Lee K.; latip J.; Seo S.Y.; Ultrasound mediated efficient synthesis of new 4-oxoquinazolin-3(4H)-yl)furan-2-carboxamides as potent tyrosinase inhibitors: Mechanistic approach through chemoinformatics and molecular docking studies. Bioorg Chem  2019,92,103201","journal-title":"Bioorg Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14756366.2018.1545767","volume":"34","author":"Zolghadri S.","year":"2019","unstructured":"Zolghadri S.; Bahrami A.; Hassan Khan M.T.; Munoz-Munoz J.; Garcia-Molina F.; Garcia-Canovas F.; Saboury A.A.; A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem  2019,34(1),279-309","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1590\/abd1806-4841.20132660.","volume":"88","author":"Mosquita K.C.","year":"2013","unstructured":"Mosquita K.C.; Igreja A.C.S.M.; Costa I.M.C.; Atopic dermatitis and vitamin D: Facts and controversies. An Bras Dermatol  2013,88(6),945-53","journal-title":"An Bras Dermatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e39803","DOI":"10.1371\/journal.pone.0039803","volume":"7","author":"Deckers I.A.G.","year":"2012","unstructured":"Deckers I.A.G.; McLean S.; Linssen S.; Mommers M.; van Schayck C.P.; Sheikh A.; Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: A systematic review of epidemiological studies. PLoS One  2012,7(7),e39803","journal-title":"PLoS One"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/jdv.12033","volume":"27","author":"Yousefi M.","year":"2013","unstructured":"Yousefi M.; Barikbin B.; Kamalinejad M.; Abolhasani E.; Ebadi A.; Younespour S.; Manouchehrian M.; Hejazi S.; Comparison of therapeutic effect of topical Nigella with Betamethasone and Eucerin in hand eczema. J Eur Acad Dermatol Venereol  2013,27(12),1498-1504","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-2002-25234","volume":"28","author":"Stern T.","year":"2002","unstructured":"Stern T.; Bayerl C.; Black cumin oil ointment, a new option for topical treatment of atopic eczema? - A prospective, double-blind, single-center, placebo-controlled study. Curr Derm  2002,28(3),74-79","journal-title":"Curr Derm"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.4049\/jimmunol.1300789.","volume":"191","author":"Brandt E. B.","year":"2013","unstructured":"Brandt E. B.; Gibson A. M.; Bass S.; Rydyznski C.; Khurana Hershey G. K.; Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice. J Immunol  2013,191(7),3519-25","journal-title":"J Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15043","volume":"32","author":"Dr\u00e9no B.","year":"2018","unstructured":"Dr\u00e9no B.; P\u00e9castaings S.; Corvec S.; Veraldi S.; Khammari A.; Roques C.; Cutibacterium acnes ( Propionibacterium acnes ) and acne vulgaris: A brief look at the latest updates. J Eur Acad Dermatol Venereol  2018,32(S2),5-14","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=24","first-page":"247","volume":"150","author":"Antiga E.","year":"2015","unstructured":"Antiga E.; Verdelli A.; Bonciani D.; Bonciolini V.; Caproni M.; Fabbri P.; Acne: A new model of immune-mediated chronic inflammatory skin disease. G Ital Dermatol Venereol  2015,150(2),247-254","journal-title":"G Ital Dermatol Venereol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/301304","volume":"2014","author":"Sinha P.","year":"2014","unstructured":"Sinha P.; Srivastava S.; Mishra N.; Yadav N.P.; New perspectives on antiacne plant drugs: Contribution to modern therapeutics. BioMed Res Int  2014,2014,1-19","journal-title":"BioMed Res Int"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.fitote.2012.03.026","volume":"83","author":"Azimi H.","year":"2012","unstructured":"Azimi H.; Fallah-Tafti M.; Khakshur A.A.; Abdollahi M.; A review of phytotherapy of acne vulgaris: Perspective of new pharmacological treatments. Fitoterapia  2012,83(8),1306-1317","journal-title":"Fitoterapia"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1128\/iai.63.8.3158-3165.1995","volume":"63","author":"Vowels B.R.","year":"1995","unstructured":"Vowels B.R.; Yang S.; Leyden J.J.; Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect Immun  1995,63(8),3158-3165","journal-title":"Infect Immun"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1365-2133.2004.05762.x","volume":"150","author":"Graham G.M.","year":"2004","unstructured":"Graham G.M.; Farrar M.D.; Cruse-Sawyer J.E.; Holland K.T.; Ingham E.; Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol  2004,150(3),421-428","journal-title":"Br J Dermatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00403-019-01908-x","volume":"311","author":"Cong T.X.","year":"2019","unstructured":"Cong T.X.; Hao D.; Wen X.; Li X.H.; He G.; Jiang X.; From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res  2019,311(5),337-349","journal-title":"Arch Dermatol Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1741-7007-9-71","volume":"9","author":"Durrant J.D.","year":"2011","unstructured":"Durrant J.D.; McCammon J.A.; Molecular dynamics simulations and drug discovery. BMC Biol  2011,9(1),71","journal-title":"BMC Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/cosmetics9060131","volume":"9","author":"Hourfane S.","year":"2022","unstructured":"Hourfane S.; Mechqoq H.; Errajouani F.; Rocha J.; El Aouad N.; In vitro and in silico evaluations of Boswellia carterii resin dermocosmetic activities. Cosmetics  2022,9(6),131","journal-title":"Cosmetics"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1021\/bi200395t","volume":"50","author":"Ismaya W.T.","year":"2011","unstructured":"Ismaya W.T.; Rozeboom H.J.; Weijn A.; Mes J.J.; Fusetti F.; Wichers H.J.; Dijkstra B.W.; Crystal structure of Agaricus bisporus mushroom tyrosinase: Identity of the tetramer subunits and interaction with tropolone. Biochemistry  2011,50(24),5477-5486","journal-title":"Biochemistry"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00018-005-5054-y","volume":"62","author":"Kim Y.J.","year":"2005","unstructured":"Kim Y.J.; Uyama H.; Tyrosinase inhibitors from natural and synthetic sources: Structure, inhibition mechanism and perspective for the future. Cell Mol Life Sci  2005,62(15),1707-1723","journal-title":"Cell Mol Life Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"116222","DOI":"10.1016\/j.bmc.2021.116222","volume":"41","author":"Vanjare B.D.","year":"2021","unstructured":"Vanjare B.D.; Choi N.G.; Mahajan P.G.; Raza H.; Hassan M.; Han Y.; Yu S.M.; Kim S.J.; Seo S.Y.; Lee K.H.; Novel 1,3,4-oxadiazole compounds inhibit the tyrosinase and melanin level: Synthesis, in-vitro , and in-silico studies. Bioorg Med Chem  2021,41,116222","journal-title":"Bioorg Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0964528419871058","volume":"38","author":"Jiao R.","year":"2020","unstructured":"Jiao R.; Yang Z.; Wang Y.; Zhou J.; Zeng Y.; Liu Z.; The effectiveness and safety of acupuncture for patients with atopic eczema: A systematic review and meta-analysis. Acupunct Med  2020,38(1),3-14","journal-title":"Acupunct Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"102950","DOI":"10.1016\/j.bioorg.2019.102950","volume":"88","author":"Karakaya G.","year":"2019","unstructured":"Karakaya G.; T\u00fcre A.; Ercan A.; \u00d6nc\u00fcl S.; Aytemir M.D.; Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives. Bioorg Chem  2019,88,102950","journal-title":"Bioorg Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.foodchem.2016.12.017","volume":"223","author":"Zhang L.","year":"2017","unstructured":"Zhang L.; Zhao X.; Tao G.J.; Chen J.; Zheng Z.P.; Investigating the inhibitory activity and mechanism differences between norartocarpetin and luteolin for tyrosinase: A combinatory kinetic study and computational simulation analysis. Food Chem  2017,223,40-48","journal-title":"Food Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1016\/j.bmc.2005.03.012","volume":"13","author":"Khan M.T.H.","year":"2005","unstructured":"Khan M.T.H.; Choudhary M.I.; Khan K.M.; Rani M.; Atta-ur-Rahman, ; Structure\u2013activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues. Bioorg Med Chem  2005,13(10),3385-3395","journal-title":"Bioorg Med Chem"},{"key":"ref=39","first-page":"2465","volume":"11","author":"Xue C.B.","year":"2019","unstructured":"Xue C.B.; Zhang L.; Luo W.C.; Xie X.Y.; Jiang L.; Xiao T.; 3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors. Bioorg Med Chem  2019,11(9),2465-30","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bioorg.2018.08.020","volume":"81","author":"\u015e\u00f6hreto\u011flu D.","year":"2018","unstructured":"\u015e\u00f6hreto\u011flu D.; Sari S.; Barut B.; \u00d6zel A.; Tyrosinase inhibition by some flavonoids: Inhibitory activity, mechanism by in vitro and in silico studies. Bioorg Chem  2018,81,168-174","journal-title":"Bioorg Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.53388\/PR202202009.","volume":"2","author":"Wu C.","year":"2022","unstructured":"Wu C.; Li W. B.; Liu Y.; Yan X. N.; Exploring the mechanism of action of San Huang lotion for the topical treatment of eczema based on network pharmacology and molecular docking techniques. TMR Pharm Res  2022,2(2),9","journal-title":"TMR Pharm Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"870","DOI":"10.21037\/apm.2020.04.17","volume":"9","author":"Ma T.","year":"2020","unstructured":"Ma T.; Chai Y.; Li S.; Sun X.; Wang Y.; Xu R.; Chen J.; Zhou M.; Zhou M.; Li B.; Xu W.; Li X.; Efficacy and safety of Qinzhuliangxue decoction for treating atopic eczema: A randomized controlled trial. Ann Palliat Med  2020,9(3),870-882","journal-title":"Ann Palliat Med"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"p. 116222","DOI":"10.1016\/j.bmc.2021.116222","volume":"vol. 41","year":"2021","unstructured":"Balasaheb D. VANJARE, CHOI, Nam Gyu, MAHAJAN, Prasad G., et al. Novel 1, 3, 4-oxadiazole compounds inhibit the tyrosinase and melanin level: Synthesis, in-vitro, and in-silico studies. Bioorganic and Medicinal Chemistry  2021,vol. 41,p. 116222","journal-title":"Bioorganic and Medicinal Chemistry"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8605743","volume":"2019","author":"Earlia N.","year":"2019","unstructured":"Earlia N.; Muslem, ; Suhendra R.; Amin M.; Prakoeswa C.R.S.; Khairan, ; Idroes R.; GC\/MS analysis of fatty acids on Pliek U oil and its pharmacological study by molecular docking to filaggrin as a drug candidate in atopic dermatitis treatment. ScientificWorldJournal  2019,2019,1-7","journal-title":"ScientificWorldJournal"},{"key":"ref=45","first-page":"113","volume":"39","author":"Zheng Y.","year":"2013","unstructured":"Zheng Y.; Lai W.; Progress in the pathogenesis of eczema. Ital J Dermatol Venereol  2013,39(2),113-115","journal-title":"Ital J Dermatol Venereol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/molecules21050623","volume":"21","author":"Mlcek J.","year":"2016","unstructured":"Mlcek J.; Jurikova T.; Skrovankova S.; Sochor J.; Quercetin and its anti-allergic immune response. Molecules  2016,21(5),623","journal-title":"Molecules"},{"key":"ref=47","first-page":"1300","volume":"25","author":"Shen R.M.","year":"2019","unstructured":"Shen R.M.; Li G.Q.; Zhong L.B.; Anti-inflammatory effect of luteolin in acute gouty arthritis model rats. Hainan Yixueyuan Xuebao  2019,25(17),1300-1303","journal-title":"Hainan Yixueyuan Xuebao"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.3892\/mmr.2017.7611","volume":"16","author":"Wang J.","year":"2017","unstructured":"Wang J.; Li K.; Li Y.; Wang Y.; Mediating macrophage immunity with wogonin in mice with vascular inflammation. Mol Med Rep  2017,16(6),8434-8440","journal-title":"Mol Med Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7532306","volume":"2020","author":"Sun Y.","year":"2020","unstructured":"Sun Y.; Gao L.; Hou W.; Wu J.; \u03b2-Sitosterol alleviates inflammatory response via inhibiting the activation of ERK\/p38 and NF-\u03baB pathways in LPS-exposed BV2 cells. BioMed Res Int  2020,2020,1-10","journal-title":"BioMed Res Int"},{"key":"ref=50","first-page":"p. 8","volume":"vol. 7","year":"2022","unstructured":"WU, Can, LI, Wen-Bin, LIU, Yong, et al. Exploring the mechanism of action of San Huang lotion for the topical treatment of eczema based on network pharmacology and molecular docking techniques. Diabetes  2022,vol. 7,p. 8","journal-title":"Diabetes"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"706836","DOI":"10.3389\/fphar.2021.706836","volume":"12","author":"Wang W.","year":"2021","unstructured":"Wang W.; Wang Y.; Zou J.; Jia Y.; Wang Y.; Li J.; Wang C.; Sun J.; Guo D.; Wang F.; Wu Z.; Yang M.; Wu L.; Zhang X.; Shi Y.; The mechanism action of German chamomile (Matricaria recutita L.) in the treatment of eczema: Based on dose-effect weight coefficient network pharmacology. Front Pharmacol  2021,12,706836","journal-title":"Front Pharmacol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1087057110388276","volume":"16","author":"Degliesposti G.","year":"2011","unstructured":"Degliesposti G.; Portioli C.; Parenti M.D.; Rastelli G.; BEAR, a novel virtual screening methodology for drug discovery. SLAS Discov  2011,16(1),129-133","journal-title":"SLAS Discov"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/1389200216666150812124801","volume":"16","author":"Liu P.F.","year":"2015","unstructured":"Liu P.F.; Hsieh Y.D.; Lin Y.C.; Two A.; Shu C.W.; Huang C.M.; Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris. Curr Drug Metab  2015,16(4),245-254","journal-title":"Curr Drug Metab"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"102652","DOI":"10.1016\/j.jddst.2021.102652","volume":"64","author":"Kildaci I.","year":"2021","unstructured":"Kildaci I.; Budama-Kilinc Y.; Kecel-Gunduz S.; Altuntas E.; Linseed oil nanoemulsions for treatment of atopic dermatitis disease: Formulation, characterization, in vitro and in silico evaluations. J Drug Deliv Sci Technol  2021,64,102652","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","volume":"31","author":"Hu X.","year":"2009","unstructured":"Hu X.; Ivashkiv L.B.; Cross-regulation of signaling pathways by interferon-\u03b3: Implications for immune responses and autoimmune diseases. Immunity  2009,31(4),539-550","journal-title":"Immunity"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","volume":"169","author":"Kim J.","year":"2002","unstructured":"Kim J.; Ochoa M.T.; Krutzik S.R.; Takeuchi O.; Uematsu S.; Legaspi A.J.; Brightbill H.D.; Holland D.; Cunliffe W.J.; Akira S.; Sieling P.A.; Godowski P.J.; Modlin R.L.; Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol  2002,169(3),1535-1541","journal-title":"J Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/14728214.2015.990373","volume":"20","author":"Aslam I.","year":"2015","unstructured":"Aslam I.; Fleischer A.; Feldman S.; Emerging drugs for the treatment of acne. Expert Opin Emerg Drugs  2015,20(1),91-101","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3897\/pharmacia.70.e113065","volume":"70","author":"Kola-Mustapha A.T.","year":"2023","unstructured":"Kola-Mustapha A.T.; De novo design of pimarane diterpenoid compounds as potential alternatives to sarecycline for acne vulgaris treatment. Pharmacia  2023,70(4),1167-1176","journal-title":"Pharmacia"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/microorganisms9020303","volume":"9","author":"Mayslich C.","year":"2021","unstructured":"Mayslich C.; Grange P.A.; Dupin N.; Cutibacterium acnes as an opportunistic pathogen: an update of its virulence-associated factors. Microorganisms  2021,9(2),303","journal-title":"Microorganisms"},{"key":"ref=60","first-page":"55","volume":"8","author":"Darusman F.","year":"2021","unstructured":"Darusman F.; Fakih T.M.; Comprehensive in silico analysis of christinin molecular behavior from Ziziphus spina-Christi leaves on Propionibacterium acnes. Pharm Sci Res  2021,8(1),55-64","journal-title":"Pharm Sci Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jid.2017.11.041","volume":"138","author":"Ghosh S.","year":"2018","unstructured":"Ghosh S.; Sinha M.; Bhattacharyya A.; Sadhasivam S.; Megha J.; Reddy S.; Saini S.; Singh H.; Kumar D.; Kaur S.P.; Mishra M.; Usharani D.; Ghosh S.; Sengupta S.; A rationally designed multifunctional antibiotic for the treatment of drug-resistant acne. J Invest Dermatol  2018,138(6),1400-1408","journal-title":"J Invest Dermatol"},{"key":"ref=62","first-page":"22","volume":"77","author":"Parenti M.D.","year":"2011","unstructured":"Parenti M.D.; Rastelli G.; Advances and applications of binding affinity prediction methods in drug discovery. Biotechnol Adv  2011,77(1),22-50","journal-title":"Biotechnol Adv"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1098\/rsif.2011.0584","volume":"9","author":"Tuffery P.","year":"2012","unstructured":"Tuffery P.; Derreumaux P.; Flexibility and binding affinity in protein\u2013ligand, protein\u2013protein and multi-component protein interactions: limitations of current computational approaches. J R Soc Interface  2012,9(66),20-33","journal-title":"J R Soc Interface"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbrc.2018.12.134","volume":"509","author":"Cheon D.","year":"2019","unstructured":"Cheon D.; Lee W.C.; Lee Y.; Lee J.Y.; Kim Y.; Structural basis of branched-chain fatty acid synthesis by Propionibacterium acnes \u03b2-ketoacyl acyl Carrier protein synthase. Biochem Biophys Res Commun  2019,509(1),322-328","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0003-9861(55)90175-2","volume":"57","author":"Krueger R.C.","year":"1955","unstructured":"Krueger R.C.; The inhibition of tyrosinase. Arch Biochem Biophys  1955,57(1),52-60","journal-title":"Arch Biochem Biophys"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0027-5107(85)90204-0","volume":"148","author":"Marnett L.J.","year":"1985","unstructured":"Marnett L.J.; Hurd H.K.; Hollstein M.C.; Levin D.E.; Esterbauer H.; Ames B.N.; Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat Res  1985,148(1-2),25-34","journal-title":"Mutat Res"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919851663","volume":"11","author":"Schvartsman G.","year":"2019","unstructured":"Schvartsman G.; Taranto P.; Glitza I.C.; Agarwala S.S.; Atkins M.B.; Buzaid A.C.; Management of metastatic cutaneous melanoma: updates in clinical practice. Ther Adv Med Oncol  2019,11","journal-title":"Ther Adv Med Oncol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"116869","DOI":"10.1016\/j.carbpol.2020.116869","volume":"250","author":"Bellan D.L.","year":"2020","unstructured":"Bellan D.L.; Biscaia S.M.P.; Rossi G.R.; Cristal A.M.; Gon\u00e7alves J.P.; Oliveira C.C.; Simas F.F.; Sabry D.A.; Rocha H.A.O.; Franco C.R.C.; Chammas R.; Gillies R.J.; Trindade E.S.; Green does not always mean go: A sulfated galactan from Codium isthmocladum green seaweed reduces melanoma metastasis through direct regulation of malignancy features. Carbohydr Polym  2020,250,116869","journal-title":"Carbohydr Polym"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-817901-7.00002-2.","volume":"63","author":"Souto E.B.","year":"2019","unstructured":"Souto E.B.; Sampaio A.C.; Campos J.R.; Martins-Gomes C.; Aires A.; Silva A.M.; Polyphenols for skin cancer: Chemical properties, structure-related mechanisms of action and new delivery systems. Studies in Natural Products Chemistry  2019,63,21-42","journal-title":"Studies in Natural Products Chemistry"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"Imran M.","year":"2019","unstructured":"Imran M.; Rauf A.; Abu-Izneid T.; Nadeem M.; Shariati M.A.; Khan I.A.; Imran A.; Orhan I.E.; Rizwan M.; Atif M.; Gondal T.A.; Mubarak M.S.; Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother  2019,112,108612","journal-title":"Biomed Pharmacother"},{"key":"ref=71","unstructured":"Agrawal, Anurag, and Giriraj T. Kulkarni. \"Molecular docking study to elucidate the anti-pruritic mechanism of selected natural ligands by desensitizing TRPV3 ion channel in Psoriasis: An in silico approach.\" Indian Journal of Biochemistry and Biophysics (IJBB)  57.5 (2020): 578-583.","journal-title":"Indian Journal of Biochemistry and Biophysics (IJBB)"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1177\/1533033818791795","volume":"17","author":"Naidoo C.","year":"2018","unstructured":"Naidoo C.; Kruger C. A.; Abrahamse H.; Photodynamic therapy for metastatic melanoma treatment: A review. Technol Cancer Res Treat  2018,17","journal-title":"Technol Cancer Res Treat"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2217\/nnm.15.134","volume":"10","author":"Tang H-C.","year":"2015","unstructured":"Tang H-C.; Chen Y-C.; Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma. Int J Nanomedicine  2015,10,3131-3146","journal-title":"Int J Nanomedicine"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"717","DOI":"10.7150\/jca.10865","volume":"6","author":"Zhou L.","year":"2015","unstructured":"Zhou L.; Yang K.; Andl T.; Wickett R.R.; Zhang Y.; Perspective of targeting cancer-associated fibroblasts in Melanoma. J Cancer  2015,6(8),717-726","journal-title":"J Cancer"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"11100","DOI":"10.1158\/0008-5472.CAN-06-2554","volume":"66","author":"King A.J.","year":"2006","unstructured":"King A.J.; Patrick D.R.; Batorsky R.S.; Ho M.L.; Do H.T.; Zhang S.Y.; Kumar R.; Rusnak D.W.; Takle A.K.; Wilson D.M.; Hugger E.; Wang L.; Karreth F.; Lougheed J.C.; Lee J.; Chau D.; Stout T.J.; May E.W.; Rominger C.M.; Schaber M.D.; Luo L.; Lakdawala A.S.; Adams J.L.; Contractor R.G.; Smalley K.S.M.; Herlyn M.; Morrissey M.M.; Tuveson D.A.; Huang P.S.; Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885. Cancer Res  2006,66(23),11100-11105","journal-title":"Cancer Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.20961\/jkpk.v6i1.47223","volume":"6","author":"Fitriani I.N.","year":"2021","unstructured":"Fitriani I.N.; Ansory H.M.; Molecular docking study of nutmeg (Myristica fragrans) constituents as anti-skin cancer agents. JKPK (Jurnal Kimia dan Pendidikan Kimia)  2021,6(1),14-22","journal-title":"JKPK (Jurnal Kimia dan Pendidikan Kimia)"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/626214","volume":"2012","author":"Kandasamy S.","year":"2012","unstructured":"Kandasamy S.; Sahu S.K.; Kandasamy K.; In silico studies on fungal metabolite against skin cancer protein (4,5-diarylisoxazole HSP90 chaperone). ISRN Dermatol  2012,2012,1-5","journal-title":"ISRN Dermatol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.31788\/RJC.2022.1526769","volume":"15","author":"Asnawi A.","year":"2022","unstructured":"Asnawi A.; Aman L.O.; Molecular docking and molecular dynamic studies: screening phytochemicals of Acalypha indica against BRAF kinase receptors for potential use in melanocytic tumors. Rasayan J Chem  2022,15(2),1352-1361","journal-title":"Rasayan J Chem"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionut.2013.10.001.","volume":"4","author":"Vijayakumar S.","year":"2014","unstructured":"Vijayakumar S.; Menakha M.; Tasiamide-B a new cyanobacterial compound for treating skin cancer. Biomed Prev Nutr  2014,4(3)","journal-title":"Biomed Prev Nutr"},{"key":"ref=80","doi-asserted-by":"publisher","DOI":"10.1101\/2022.02.28.482167","author":"Boateng S.T.","year":"2022","unstructured":"Boateng S.T.; Roy T.; Agbo M.E.; Banang-Mbeumi S.; Chamcheu R.C.N.; Bramwell M.; Chamcheu J.C.; Identification of potential inhibitors of cutaneous melanoma and non-melanoma skin cancer cells through in-vitro and in-silico screening of a small library of phenolic compounds. BioRxiv  2022","journal-title":"BioRxiv"},{"key":"ref=81","first-page":"98","volume":"46","author":"Ballavi M.S.","year":"2020","unstructured":"Ballavi M.S.; Pramod Kumar H.S.; In-silico analysis to determine the efficient drug for malignant melanoma using molecular dynamics. Biomed Pharmacol J  2020,46(2),98-10","journal-title":"Biomed Pharmacol J"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.3390\/molecules28135108","volume":"28","author":"Sharma S.","year":"2023","unstructured":"Sharma S.; Kumar V.; Yaseen M.; S Abouzied A.; Arshad A.; Bhat M.A.; Naglah A.M.; Patel C.N.; Sivakumar P.K.; Sourirajan A.; Shahzad A.; Dev K.; Phytochemical analysis, in vitro biological activities, and computer-aided analysis of Potentilla nepalensis hook compounds as potential melanoma inhibitors based on molecular docking, MD simulations, and ADMET. Molecules  2023,28(13),5108","journal-title":"Molecules"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1080\/07391102.2023.2233629","volume":"42","author":"Boutalaka M.","year":"2024","unstructured":"Boutalaka M.; El bahi S.; Alaqarbeh M.; El Alaouy M.A.; Koubi Y.; Khatabi K.E.; Maghat H.; Bouachrine M.; Lakhlifi T.; Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies. J Biomol Struct Dyn  2024,42(10),5268-5287","journal-title":"J Biomol Struct Dyn"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"843970","DOI":"10.3389\/fchem.2022.843970","volume":"10","author":"Hu Y.","year":"2022","unstructured":"Hu Y.; Wu Y.; Jiang C.; Wang Z.; Shen C.; Zhu Z.; Li H.; Zeng Q.; Xue Y.; Wang Y.; Liu L.; Yi Y.; Zhu H.; Liu Q.; Investigative on the molecular mechanism of licorice flavonoids anti-melanoma by network pharmacology, 3D\/2D-QSAR, molecular docking, and molecular dynamics simulation. Front Chem  2022,10,843970","journal-title":"Front Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.bmcl.2017.02.072","volume":"27","author":"Dao P.","year":"2017","unstructured":"Dao P.; Lietha D.; Etheve-Quelquejeu M.; Garbay C.; Chen H.; Synthesis of novel 1,2,4-triazine scaffold as FAK inhibitors with antitumor activity. Bioorg Med Chem Lett  2017,27(8),1727-1730","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=86","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10839-3","author":"Hang N.T.","year":"2024","unstructured":"Hang N.T.; My T.T.K.; Van Anh L.T.; Van Anh P.T.; Anh T.D.H.; Van Phuong N.; Identification of potential FAK inhibitors using mol2vec molecular descriptor-based QSAR, molecular docking, ADMET study, and molecular dynamics simulation. Mol Divers  2024","journal-title":"Mol Divers"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.sbi.2011.09.008","volume":"21","author":"Arold S.T.","year":"2011","unstructured":"Arold S.T.; How focal adhesion kinase achieves regulation by linking ligand binding, localization and action. Curr Opin Struct Biol  2011,21(6),808-813","journal-title":"Curr Opin Struct Biol"},{"key":"ref=88","first-page":"2752","volume":"55","author":"Owens L.V.","year":"1995","unstructured":"Owens L.V.; Xu L.; Craven R.J.; Dent G.A.; Weiner T.M.; Kornberg L.; Liu E.T.; Cance W.G.; Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res  1995,55(13),2752-2755","journal-title":"Cancer Res"},{"key":"ref=89","first-page":"1","author":"Shirvani P.","year":"2021","unstructured":"Shirvani P.; Fassihi A.; In silico design of novel FAK inhibitors using integrated molecular docking, 3D-QSAR and molecular dynamics simulation studies. J Biomol Struct Dyn  2021,1-19","journal-title":"J Biomol Struct Dyn"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1007\/s00044-013-0768-0","volume":"23","author":"Lu X.","year":"2014","unstructured":"Lu X.; Zhao L.; Xue T.; Zhang H.; Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking. Med Chem Res  2014,23(4),1976-1997","journal-title":"Med Chem Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/molecules28031464.","volume":"28","author":"Ghosh S.","year":"2023","unstructured":"Ghosh S.; Seung J.; Three-dimensional-QSAR and relative binding affinity estimation of focal adhesion kinase inhibitors. Molecules  2023,28(3),1464","journal-title":"Molecules"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"103144","DOI":"10.1016\/j.arabjc.2021.103144.","volume":"14","author":"Wang F.","year":"2021","unstructured":"Wang F.; Yang W.; Li R.; Sui Z.; Cheng G.; Zhou B.; Molecular description of pyrimidine-based inhibitors with activity against FAK combining 3D-QSAR analysis, molecular docking and molecular dynamics. Arab J Chem  2021,14(6),103144","journal-title":"Arab J Chem"},{"key":"ref=93","first-page":"131","volume":"137","author":"Abbas S. R.","year":"2020","unstructured":"Abbas S. R.; Baig S.; Treatment of skin cancer by medicinal plants. J Biotechnol Sci  2020,137(2),131-137","journal-title":"J Biotechnol Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/13854046.2019.1707285.","volume":"35","author":"Scott T.M.","year":"2021","unstructured":"Scott T.M.; Morlett Paredes A.; Taylor M.J.; Umlauf A.; Artiola I Fortuny L.; Heaton R.K.; Cherner M.; Marquine M.J.; Rivera Mindt M.; Demographically-adjusted norms for the WAIS-R block design and arithmetic subtests: Results from the neuropsychological norms for the US-Mexico border region in Spanish (NP-NUMBRS) project. Clin Neuropsychol  2021,35(2),419-432","journal-title":"Clin Neuropsychol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/rej.2019.2242.","volume":"22","author":"Calimport S.R.G.","year":"2019","unstructured":"Calimport S.R.G.; Bentley B.L.; Aging classified as a cause of disease in ICD-11. Rejuvenation Res  2019,22(4),281","journal-title":"Rejuvenation Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.26355\/eurrev_201806_15282.","volume":"22","author":"Zhang S.","year":"2018","unstructured":"Zhang S.; Zhang Y.; Isoflurane reduces endotoxin-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes. Eur Rev Med Pharmacol Sci  2018,22(12),3976-3987","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5223\/pghn.2017.20.3.153.","volume":"20","author":"Woodley F.W.","year":"2017","unstructured":"Woodley F.W.; Moore-Clingenpeel M.; Machado R.S.; Nemastil C.J.; Jadcherla S.R.; Hayes D Jr.; Kopp B.T.; Kaul A.; Di Lorenzo C.; Mousa H.; Not all children with cystic fibrosis have abnormal esophageal neutralization during chemical clearance of acid reflux. Pediatr Gastroenterol Hepatol Nutr  2017,20(3),153-159","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/toxins10050177.","volume":"10","author":"Amorim F.G.","year":"2018","unstructured":"Amorim F.G.; Costa T.R.; Baiwir D.; De Pauw E.; Quinton L.; Sampaio S.V.; Proteopeptidomic, functional and immunoreactivity characterization of Bothrops moojeni snake venom: Influence of snake gender on venom composition. Toxins (Basel)  2018,10(5),177","journal-title":"Toxins (Basel)"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e2890","DOI":"10.1002\/btpr.2890.","volume":"35","author":"de Andrades D.","year":"2019","unstructured":"de Andrades D.; Graebin N.G.; Ayub M.A.Z.; Fernandez-Lafuente R.; Rodrigues R.C.; Preparation of immobilized\/stabilized biocatalysts of \u03b2-glucosidases from different sources: Importance of the support active groups and the immobilization protocol. Biotechnol Prog  2019,35(6),e2890","journal-title":"Biotechnol Prog"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/09603123.2020.1757043.","volume":"32","author":"Tumola M.R.","year":"2022","unstructured":"Tumola M.R.; Panico A.; De Donno A.; Mincarone P.; Leo C.G.; Guarino R.; Bagordo F.; Serio F.; Idolo A.; Grassi T.; Sabina S.; The expression of microRNAs and exposure to environmental contaminants related to human health: A review. Int J Environ Health Res  2022,32(2),332-354","journal-title":"Int J Environ Health Res"},{"key":"ref=101","unstructured":"Available from:  https:\/\/pubchem.ncbi.nlm.nih.gov\/"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266337405240926114604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234948\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266337405240926114604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T16:15:00Z","timestamp":1747844100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234948\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680266337405240926114604","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}